Role of NFκB in the mortality of sepsis

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 972-985

  Böhrer, Hubert ^a,e   Qiu, Feng ^a   Zimmermann, Thomas ^b   Zhang, Youming ^a   Jllmer, Thomas ^b   Männel, Daniela ^c   Böttiger, Bernd W ^a   Stern, David M ^d   Waldherr, Rüdiger ^a   Saeger, Hans Detlev ^b   Ziegler, Reinhard ^a   Bierhaus, Angelika ^a   Martin, Eike ^a   Nawroth, Peter P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e Dept of Anesthesiology ^*  (Germany)

Author keywords

Coagulation; NF B; Sepsis; Tissue factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENDOTOXEMIA; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; ADULT; AGED; ANIMAL; BAGG ALBINO MOUSE; BLOOD CLOTTING; DRUG EFFECT; MALE; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ANIMALS; BLOOD COAGULATION; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NF-KAPPA B; SEPSIS; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030611086     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119648     Document Type: Article

References (67)

1. Centers for Disease Control (CDC). 1990. Morb. Mortal. Wkly. Rep. 39: 31-34.
2. Zuckerman, S.H., G.F. Evans, and L. Guthrie. 1991. Transcriptional and post-transcriptional mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunology. 73:460-465.
3. Mohri, M., D.R. Spriggs, and D. Kufe. 1990. Effects of lipopolysaccharide on phospholipase A2 activity and tumor necrosis factor expression in HL-60 cells. J. Immunol. 144:2678-2682.
4. Mai, U.E., G.I. Perez-Perez, L.M. Wahl, S.M. Wahl, M.J. Blaser, and P.D. Smith. 1991. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J. Clin. Invest. 87:894-900.
5. Ray, A., M. Hannink, and B.K. Ray. 1995. Concerted participation of NF-kappa B and C/EBP heteromers in lipopolysaccharide induction of serum amyloid A gene expression in liver. J. Biol. Chem. 270:7365-7374.
6. Geng, Y., E. Gulbins, A. Altman, and M. Lotz. 1994. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. USA. 91:8602-8606.
7. Tebo, J.M., W. Chaoqun, Y. Ohmori, and T.A. Hamilton. 1994. Murine inhibitory protein-kappa B alpha negatively regulates kappa B-dependent transcription in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Immunol. 153:4713-4720.
8. Tran-Thi, T.-A., K. Decker, and P.A. Baeuerle. 1995. Differential activation of transcription factor NFκB and AP-1 in rat liver macrophages. Hepatology. 22:613-619.
9. Read, M.A., S.R. Cordle, R.A. Veach, C.D. Carlisle, and J. Hawiger. 1993. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc. Natl. Acad. Sci. USA. 90:9887-9891.
10. Ding, A., S. Hwang, H.M. Lander, and Q.W. Xie. 1995. Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappa B. J. Leukocyte Biol. 57:174-179.
11. Zuckerman, S.H., and G.F. Evans. 1992. LPS tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell. Immunol. 140:513-519.
12. Parry, G.C.N., and N. Mackman. 1995. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler. Thromb. 15: 612-621.
13. Bierhaus, A., C.J. Hemmer, N. Mackman, R. Kutob, R. Ziegler, M. Dietrich, and P.P. Nawroth. 1995. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NFκB activation. Thromb. Haemostasis. 73:39-48.
14. Oeth, P.A., G.C.N. Parry, C. Kunsch, P. Nantermet, C.A. Rosen, and N. Mackman. 1994. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappaB-like site. Mol. Cell. Biol. 14:3772-3781.
15. Parry, G.C.N., and N. Mackman. 1994. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappaB-like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem. 269:20823-20825.
16. Moler, K.M., P.R. Sleath, J.N. Fitzner, D.P. Cerretti, M. Alderson, S.S. Kerwar, D.S. Torrance, C. Otten-Evans, T. Greenstreet, and K. Weerawarna. 1994. Protection against a lethal dose of LPS by an inhibitor of tumor necrosis factor processing. Nature (Lond.). 370:218-220.
17. Torti, F.M., B. Dieckmann, B. Beutler, A. Cerami, and G.M. Ringold. 1985. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science (Wash. DC). 229:867-869.
18. Tracey, K.J., B. Beutler, S.G. Lowry, J. Merryweather, S. Wolpe, I.W. Milsark, R.J. Hariri, T.J. Fahey III, A. Zentella, J.D. Albert, et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science (Wash. DC). 234:470-474.
19. Tracey, K.J., Y. Fong, D.G. Hesse, K.R. Monogue, A.T. Lee, G.C. Kuo, S.T. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature (Lond.). 330:662-664.
20. Ashkenazi, A., S.A. Marsters, D.J. Capon, S.M. Chamow, I.S. Figari, D. Pennica, D.V. Goeddel, M.A. Palladino, and D.H. Smith. 1991. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA. 88:10535-10539.
21. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P.H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91-98.
22. Pfeffer, K., T. Matsuyama, T.M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Kronke, and T.W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:457-467.
23. Van der Poll, T., M. Levi, S.J.H. Van Deventer, H. ten Cate, B.L. Haagmans, B.J. Biemond, H.R. Büller, C.E. Hack, and J.W. ten Cate. 1994. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood. 83: 446-451.
24. Wheeler, A.P., and G.R. Bernard. 1996. Applications of molecular biology and biotechnology: antibody therapy of sepsis. J. Crit. Care. 11:77-94.
25. Reinhart, K., C. Wiegand-Lohnert, F. Grimminger, M. Kaul, S. Withington, and D. Treacher. 1996. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment. MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit. Care Med. 24:733-742.
26. von-der-Mohlen, M.A., T. van-der-Poll, J. Jansen, M. Levi, and S.J. van-Deventer. 1996. Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor. J. Immunol. 156:4969-4973.
27. Edgington, T.S., N. Mackman, S.T. Fan, and W. Ruf. 1992. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. Nouv. Rev. Fr. Hematol. 34:S15-S37.
28. Mackman, N., M.S. Sawdey, M.R. Keeton, and D.J. Loskutoff. 1993. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am. J. Pathol. 143:76-84.
29. Colucci, M., G. Balconi, R. Lorenzet, A. Pietra, D. Locati, M.B. Donati, and N. Semeraro. 1983. Cultured human endothelial cells generate tissue factor in response to LPS. J. Clin. Invest. 71:1893-1896.
30. Bierhaus, A., Y. Zhang, Y. Deng, N. Mackman, P. Quehenberger, M. Haase, T. Luther, M. Müller, H. Bohrer, J. Greten, et al. 1995. Mechanism of the tumor necrosis factor α-mediated induction of endothelial tissue factor. J. Biol. Chem. 270:26419-26432.
31. Moll, T., M. Czyz, H. Holzmuller, R. Hofer-Warbinek, E. Wagner, H. Winkler, F.H. Bach, and E. Hofer. 1995. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J. Biol. Chem. 270:3849-3857.
32. Mackman, N. 1995. Regulation of the tissue factor gene. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:883-889.
33. Mackman, N. 1994. Protease inhibitor blocks lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J. Biol. Chem. 269:26363-26367.
34. Donovan-Peluso, M.D., L.D. George, and C.A. Hassett. 1994. Lipopolysaccharide induction of tissue factor expression in THP-1 monocytic cells. J. Biol. Chem. 269:1361-1369.
35. Nawroth, P.P., and D.M. Stern. 1986. Modulation of endothelial cell hemostatic properties by TNF. J. Exp. Med. 164:740-745.
36. Bevilacqua, M., J. Pober, G. Majeau, W. Fiers, R. Cotran, and M. Gimbrone. 1986. Recombinant TNF induces procoagulant activity in endothelium. Proc. Natl. Acad. Sci. USA. 83:4533-4537.
37. Nawroth, P.P., D. Handley, C.T. Esmon, and D.M. Stern. 1986. Interleukin 1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. Proc. Natl. Acad. Sci. USA. 83:3460-3464.
38. Conway, E.M., B. Ronald, D.R. Robert, and H.K. William. 1989. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb. Res. 53:231-241.
39. Nawroth, P.P., D. Handley, G. Matsueda, R.D. Waal, H. Gerlach, D. Blohm, and D. Stern. 1988. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth-A fibrosarcomas. J. Exp. Med. 168:637-647.
40. Lyberg, T., K.S. Galdal, S.A. Evensen, and H. Prydz. 1983. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J. Haematol. 53:85-95.
41. Carson, S.D., and R.J. Donald. 1990. Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. Blood. 76:361-367.
42. Tannenbaum, S.H., F. Rena, and B.C. Douglas. 1986. Antibody and immune complexes induce tissue factor production by human endothelial cells. J. Immunol. 137:1532-1537.
43. Edwards, R.L., and F.R. Rickles. 1980. The role of human T cells (and T cell products) for monocyte tissue factor generation. J. Immunol. 125:606-609.
44. Zhang, Y.M., Y.D. Deng, T. Wendt, B. Liliensiek, A. Bierhaus, J. Greten, W. He, B.S. Chen, V. Hach-Wunderle, R. Waldherr, et al. 1996. Intravenous somatic gene transfer with antisense-tissue factor restores blood flow by reducing tumor necrosis factor induced tissue factor expression and fibrin deposition in mouse Meth-A sarcomas. J. Clin. Invest. 97:2213-2224.
45. Warr, T.A., L.V.M. Rao, and S.I. Rapaport. 1990. Disseminated intravascular coagulation in rabbits induced by administration of LPS or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood. 75:1481-1489.
46. Levi, M., H. ten Cate, K.A. Bauer, T. van der Poll, T.S. Edgington, H.R. Büller, S.J.H. Deventer, C.E. Hack, J. Wouter ten Cate, and R.D. Rosenberg. 1994. Inhibition of LPS-induced activation of coagulation and fibrinolysis by pentoxyphilline or by a monoclonal anti-tissue factor antibody in chimpanzees. J. Clin. Invest. 93:114-120.
47. Taylor, F.B., Jr., A. Chang, W. Ruf, J.H. Morrissey, L. Hinshaw, R. Catlett, K. Blick, and T.S. Edgington. 1991. Lethal E. coli septic shock is prevented by blocking tissue factor with a monoclonal antibody. Circ. Shock. 33: 127-134.
48. Biemond, B.J., M. Levi, H. ten Cate, H.R. Soule, L.D. Morris, D.L. Foster, C.A. Bogowitz, T. Van der Poll, and H.R. Büller. 1995. Complete inhibition of LPS-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb. Haemostasis. 73:223-230.
49. Fiedler, V.B., I. Loof, E. Sander, V. Voehringer, C. Galanos, and M.A. Fournel. 1992. Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. J. Lab. Clin. Med. 120:574-588.
50. Ryan, J., J. Brett, P. Tijburg, R.R. Bach, W. Kisiel, and D. Stern. 1992. Tumor necrosis factor a induced endothelial tissue factor is associated with sub-endothelial matrix vesicles but is not expressed on the apical surface. Blood. 80: 966-974.
51. Galanos, C., M.A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of LPS. Proc. Natl. Acad. Sci. USA. 76:5939-5943.
52. Lehmann, V., M.A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657-663.
53. Hartzell, S., K. Ryder, A. Lanahan, L.F. Lau, and D. Nathans. 1989. A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol. Cell. Biol. 9:2567-2573.
54. Mackman, N., B.J. Fowler, T.S. Edgington, and J.H. Morrissey. 1990. Functional analysis of the human tissue factor promoter and induction by serum. Proc. Natl. Acad. Sci. USA. 7:2254-2258.
55. Nolan, G.P., S. Ghosh, H.C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a Rel-related polypeptide. Cell. 64:961-969.
56. Bohmann, D., and R. Tjian. 1989. Biochemical analysis of transcriptional activation by Jun: differential activity of c-and v-Jun. Cell. 59:709-717.
57. Andrews, N.C., and D.V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucl. Acids Res. 19:2499.
58. Deryckere, F., and F. Gannon. 1994. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques. 16:405.
59. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
60. Pahl, H.L., and P.A. Baeuerle. 1995. Expression of influenza virus hemagglutinin activates transcription factor NFκB. J. Virol. 69:1480-1484.
61. de Wet, J.R., K.V. Wood, M. DeLuca, D.R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725-737.
62. Alam, J., and J.L. Cook. 1990. Reporter genes: application to the study of mammalian gene transcription. Anal. Biochem. 188:245-256.
63. Larsson, L.I. 1989. Immunocytochemistry: Theory and Practice. CRC Press, Inc., Boca Raton, FL. 95-96.
64. Zhang, Y.M., S. Bachmann, C. Hemmer, J. van Lunzen, A. von Stemm, P. Kern, M. Dietrich, R. Waldherr, and P.P. Nawroth. 1994. Vascular origin of Kaposi's sarcoma: expression of leukocyte adhesion molecule-1, thrombodulin, and tissue factor. Am. J. Pathol. 144:51-59.
65. Creasey, A.A., A.C.K. Chang, L. Feigen, T.C. Wün, F.B. Taylor, Jr., and L.B. Hinshaw. 1993. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J. Clin. Invest. 91:2850-2860.
66. O'Riordain, M.G., D.S. O'Riordain, R.G. Molloy, J.A. Mannick, and M.L. Rodrick. 1996. Dosage and timing of anti-TNF-alpha antibody treatment determine its effect of resistance to sepsis after injury. J. Surg. Res. 64:95-101.
67. Lasch, H.G., D.C. Heene, K. Huth, and W. Sandritter. 1967. Pathophysiology, clinical manifestation and theory of consumption coagulopathy. Am. J. Cardiol. 20:381-391.